✦ LIBER ✦

The efficacy and safety of mizoribine in living donor kidney transplantation: a 24-week, open-label, prospective study (phase III clinical trial)

✍ Scribed by D.K. Cho; J.H. Kim; S.H. Park; J.C. Kim; C.D. Kim; M.Y. Baek; S.J. Kim; S.H. Kim; T.H. Kwon; Y.L. Kim; Y.W. Kim; S.K. Chang

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of efalizumab for sc

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Safety of efalizumab for the treatment o

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Efficacy of efalizumab for the treatment

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Efficacy and safety of efalizumab in adu

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 48 KB

A single-center open label randomized tr

✍ P.G.P Machado; C Garcia; C.R Felipe; R Garcia; M Franco; R Delcelo; H.T Silva Jr 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 63 KB

A 24-week, open-label extension to the A

✍ Farlow, Martin; Grossberg, George; Sadowsky, Carl; Meng, Xiangyi; Somogyi, Moniq 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 51 KB